| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.38 | 0.02 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.42 | 0.02 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |